BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17347847)

  • 1. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome.
    Han AR; Lee HR; Park BB; Hwang IG; Park S; Lee SC; Kim K; Lim HY; Ko YH; Kim SH; Kim WS
    Ann Hematol; 2007 Jul; 86(7):493-8. PubMed ID: 17347847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphoma-associated hemophagocytic syndrome in Japan].
    Takahashi N; Chubachi A; Miura I; Nakamura S; Miura AB
    Rinsho Ketsueki; 1999 Jul; 40(7):542-9. PubMed ID: 10483136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and treatment outcomes of peripheral T-cell lymphoma, unspecified: a report of 78 cases].
    Yu YX; Shi YK; He XH; Zhou LQ; Zhou SY; Dong M; Feng FY; Sun Y
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2714-6. PubMed ID: 18167252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
    Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
    Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature.
    Go RS; Wester SM
    Cancer; 2004 Sep; 101(6):1404-13. PubMed ID: 15368328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma.
    Li CC; Tien HF; Tang JL; Yao M; Chen YC; Su IJ; Hsu SM; Hong RL
    Cancer; 2004 Jan; 100(2):366-75. PubMed ID: 14716773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
    Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
    Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
    Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lymphoma-associated hemophagocytic syndrome(LAHS)].
    Takahashi N
    Nihon Rinsho; 2000 Mar; 58(3):665-8. PubMed ID: 10741143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
    Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
    Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
    Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and prognostic factors of patients with "peripheral T cell lymphoma, unspecified".
    Lee Y; Uhm JE; Lee HY; Park MJ; Kim H; Oh SJ; Jang JH; Kim K; Jung CW; Ahn YC; Park K; Ko YH; Kim WS
    Ann Hematol; 2009 Feb; 88(2):111-9. PubMed ID: 18648812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis.
    Song Y; Yin Q; Wang J; Wang Z
    Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
    Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
    Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults.
    Tseng YT; Sheng WH; Lin BH; Lin CW; Wang JT; Chen YC; Chang SC
    J Microbiol Immunol Infect; 2011 Jun; 44(3):191-7. PubMed ID: 21524613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience.
    Rodríguez J; Conde E; Gutiérrez A; Arranz R; Gandarillas M; Leon A; Ojanguren J; Sureda A; Carrera D; Bendandi M; Moraleda J; Ribera JM; Albo C; Morales A; García JC; Fernández P; Cañigral G; Bergua J; Caballero MD;
    Eur J Haematol; 2007 Apr; 78(4):290-6. PubMed ID: 17378891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.